Navigation

Clinical Research

Our team of highly trained specialists is dedicated to offering patients the most advanced treatment available for their condition through clinical research.

Adult Neurology and Neurosurgery Clinical Trials

If you are interested in learning more about one of our ongoing clinical trials, please feel free to call our Clinical Research Program at 520-320-2147.

Alzheimer’s Disease Clinical Trial – Now Enrolling

Early Alzheimer’s Disease: ENGAGE

The ENGAGE Study is a global study assessing the efficacy and safety of an investigational medication, to determine whether it can slow the progression of symptoms in early Alzheimer’s disease.

Alzheimer’s Disease Clinical Trial – Now Enrolling

Early Alzheimer’s Study: GRADUATE

This study is comparing the effects of an investigational drug versus placebo on participants and their memory problems.

Multiple Sclerosis Clinical Trial – Now Enrolling

Multiple Sclerosis Study: PASSAGE

The PASSAGE study is a long-term study monitoring safety in patients newly started on pharmaceutical therapy for MS.

Multiple Sclerosis Clinical Trial – Now Enrolling

Multiple Sclerosis Study: FLUENT

The FLUENT MS study is for patients who have relapsing MS and who will begin fingolimod therapy or have been taking fingolimod therapy for at least 2 years.

Glioblastoma Clinical Trial – Now Enrolling

Recurrent Glioblastoma Study

This study is of an investigational oral medication in patients with recurrent glioblastoma.

Glioblastoma Clinical Trial – Now Enrolling

Recurrent Glioblastoma Study: VOYAGER

The VOYAGER study is a feasibility study of a device worn on the head for recurrent glioblastoma.

Glioblastoma Clinical Trial – Now Enrolling

Glioblastoma Study: Boston Bio

This study will help us learn more about a newly discovered vaccine drug that is being tested in people with recurrent or progressive glioblastoma, who have already received treatment.